Cargando…

Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

Detalles Bibliográficos
Autores principales:	Li, Weidong, Dong, Xuesong, He, Changjun, Tan, Gang, Li, Ziyi, Zhai, Bo, Feng, Jing, Jiang, Xian, Liu, Chang, Jiang, Hongchi, Sun, Xueying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638182/ https://www.ncbi.nlm.nih.gov/pubmed/34852817 http://dx.doi.org/10.1186/s13046-021-02183-3

Ejemplares similares

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2019)

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
por: He, Changjun, et al.
Publicado: (2015)

An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
por: Tang, Shuyao, et al.
Publicado: (2016)

Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
por: Han, Peng, et al.
Publicado: (2017)

LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis
por: Zhu, Huaqiang, et al.
Publicado: (2020)

Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na(+)/K(+)-ATPase activity and hypoxia-inducible pathways
por: Jiang, Wenjing, et al.
Publicado: (2018)

Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Dongyan, et al.
Publicado: (2016)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma
por: Guo, Zhenli, et al.
Publicado: (2019)

High expression of lncRNA-SNHG7 is associated with poor prognosis in hepatocellular carcinoma
por: Shen, An, et al.
Publicado: (2020)

LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway
por: Shen, Qian, et al.
Publicado: (2020)

LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression
por: Chen, Hang, et al.
Publicado: (2019)

LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
por: Fei, Fan, et al.
Publicado: (2018)

The prognostic value of lncRNA SNHG6 in cancer patients
por: Shen, Haixiang, et al.
Publicado: (2020)

LncRNA SNHG6 role in clinicopathological parameters in cancers
por: Khan, Khushbukhat, et al.
Publicado: (2023)

Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma
por: Huang, Jingjing, et al.
Publicado: (2022)

The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis
por: Dong, Bingzi, et al.
Publicado: (2019)

Characterization of LncRNA SNHG22 as a protector of NKIRAS2 through miR-4492 binding in osteosarcoma
por: Zheng, Huo-Liang, et al.
Publicado: (2020)

LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis
por: Niu, Yuexiang, et al.
Publicado: (2020)

LncRNA SNHG6 promotes glycolysis reprogramming in hepatocellular carcinoma by stabilizing the BOP1 protein
por: Chen, Kai, et al.
Publicado: (2022)

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Li, Xinyan, et al.
Publicado: (2022)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition
por: Xu, Wenrui, et al.
Publicado: (2020)

LncRNA SNHG3, a potential oncogene in human cancers
por: Xu, Bin, et al.
Publicado: (2020)

LncRNA SNHG1: role in tumorigenesis of multiple human cancers
por: Zeng, Huang, et al.
Publicado: (2023)

Corrigendum: identification and validation of lncRNA-SNHG17 in lung adenocarcinoma: a novel prognostic and diagnostic indicator
por: Li, Xinyan, et al.
Publicado: (2022)

LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p
por: Xiao, Xiao, et al.
Publicado: (2021)

Retraction: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2021)

Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis
por: Zhang, Yunyuan, et al.
Publicado: (2022)

LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
por: Fan, Xiaoxi, et al.
Publicado: (2021)

Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

lncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through PGK1/Akt/mTOR signal pathway
por: Jiang, Qingkun, et al.
Publicado: (2021)

lncRNA SNHG3 promotes breast cancer progression by acting as a miR-326 sponge
por: Zhang, Haipeng, et al.
Publicado: (2020)

lncRNA SNHG3 promotes breast cancer progression by acting as a miR-326 sponge
por: Zhang, Haipeng, et al.
Publicado: (2022)

LncRNA SNHG3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-139-5p/MYB axis
por: Xie, Yan, et al.
Publicado: (2021)

The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer
por: Jiao, Yan, et al.
Publicado: (2020)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma
por: Yu, Yongbo, et al.
Publicado: (2019)

LncRNA SNHG15: A new budding star in human cancers
por: Shuai, You, et al.
Publicado: (2019)

Expression of Concern: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3qfn2scebb1ic8lsho2bbf4rg5